See also this year's filing and all EDGAR filings for this company.
PDF Report 0001062822_2023_Lexicon_Pharmaceuticals_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 1.6988040285354595, 'aggregate_val': 77175000, 'exp_sum': 28596000, 'exp_to_value': {'LiabilitiesCurrent': 23172000, 'LiabilitiesNoncurrent': 5424000, 'remainder_Liabilities': 0}} |
Graph
Absolute values for 0001062822, Lexicon Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 140,866,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 44,543,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,071,000 |
| 3 | remainder_Assets | 6,819,000 |
| 4 | LiabilitiesCurrent | 23,172,000 |
| 5 | LiabilitiesNoncurrent | 5,424,000 |
| 6 | remainder_Liabilities | 48,579,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 47,435,661 |
| 9 | ResearchAndDevelopmentExpense | 53,401,255 |
| 10 | remainder_Expenses | 2,565,269 |
| 11 | remainder_Revenues | 187,733 |
| 12 | remainder_NetIncome | 1,088,637 |
| 13 | remainder_ComprehensiveNetIncome | -361,551 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 194,299,000 |
| 1 | Liabilities | 77,175,000 |
| 2 | Expenses | 103,402,185 |
| 3 | Revenues | 187,733 |
| 4 | StockholdersEquity | 117,124,000 |
| 5 | NetIncome | -102,125,815 |
| 6 | ComprehensiveNetIncome | -102,306,590 |
| 7 | BaseVar | 188,257,053 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.13 |
| 9 | EconomicCapitalRatio | 2.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
